|
BECN1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.557400E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.498700E-03 |
| Normal-vs-Stage2 |
8.518000E-02 |
| Normal-vs-Stage3 |
2.766400E-02 |
| Normal-vs-Stage4 |
3.499600E-02 |
| Stage1-vs-Stage2 |
9.071000E-01 |
| Stage1-vs-Stage3 |
7.090200E-01 |
| Stage1-vs-Stage4 |
9.440200E-01 |
| Stage2-vs-Stage3 |
8.947800E-01 |
| Stage2-vs-Stage4 |
8.746200E-01 |
| Stage3-vs-Stage4 |
7.343800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.495000E-03 |
| Normal-vs-AfricanAmerican |
9.010900E-04 |
| Normal-vs-Asian |
8.270500E-02 |
| Caucasian-vs-AfricanAmerican |
2.089800E-01 |
| Caucasian-vs-Asian |
9.417800E-01 |
| AfricanAmerican-vs-Asian |
2.747600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.511500E-02 |
| Normal-vs-Female |
2.196000E-03 |
| Male-vs-Female |
5.546400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.899700E-03 |
| Normal-vs-Age(41-60Yrs) |
2.615900E-02 |
| Normal-vs-Age(61-80Yrs) |
4.185700E-02 |
| Normal-vs-Age(81-100Yrs) |
1.853780E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.824400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.827800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.341800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.376000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.786400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.973200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
9.188200E-01 |
| Classical-VS-Follicular |
7.402300E-03 |
| Classical-VS-Other |
4.143900E-02 |
| Classical-VS-Normal |
9.70599999999822E-05 |
| Tall-VS-Follicular |
3.525900E-02 |
| Tall-VS-Other |
4.485600E-02 |
| Tall-VS-Normal |
5.702800E-03 |
| Follicular-VS-Other |
5.291600E-01 |
| Follicular-VS-Normal |
7.794000E-01 |
| Other-VS-Normal |
5.734800E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.362400E-02 |
| Normal-vs-N1 |
5.154200E-01 |
| N0-vs-N1 |
6.159200E-01 |
|
|
